Unknown NA INTERVENTIONAL 1-arm NCT04963959

PBMC Collection for Production of UCAR T Cells

A Study on the Collection of Peripheral Blood Mononuclear Cells From Healthy Volunteers for UCAR T Production and Clinical Investigation

Sponsor: CARsgen Therapeutics Co., Ltd.

Conditions Peripheral Blood Mononuclear Cell

Interventions Peripheral blood mononuclear cell apheresis

Updated 5 times since 2021 Last updated: Nov 3, 2021 Started: Jul 14, 2021 Primary completion: Dec 31, 2021 Completion: Jan 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Peripheral Blood Mononuclear Cell and is currently ongoing. CARsgen Therapeutics Co., Ltd. leads this study, which shows 5 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jul 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Dec 2021 — Jul 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2021 — Dec 2021 [monthly]

Not Yet Recruiting NA

First recorded

Jul 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CARsgen Therapeutics Co., Ltd.
The First Affiliated Hospital of Soochow University

Data source: The First Affiliated Hospital of Soochow University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Suzhou, China